Digital PCR and Real-time PCR Market by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, CRO) - Forecast to 2022

  • ID: 4319022
  • Report
  • 218 Pages
  • Markets and Markets
1 of 5
The Global Digital PCR and Real-Time PCR (qPCR) Market is Estimated to Grow at a CAGR of 8.9% from 2017 to 2022 to Reach USD 5.31 Billion by 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Bioneer Corporation
  • Denville Scientific Inc.
  • Eppendorf AG
  • Formulatrix, Inc.
  • Promega Corporation
  • MORE

"The global digital PCR and real-time (qPCR) market projected to grow at a CAGR of 8.9%."

The global dPCR and qPCR market is estimated to grow at a CAGR of 8.9% from 2017 to 2022, to reach USD 5.31 billion by 2022. The key factors driving the growth of this market include growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, increasing investments and availability of funds for PCR-based research, and increasing use of biomarker profiling for disease diagnosis. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market.

"The dPCR technology segment to grow at faster pace than qPCR technology segment during the forecast period."

Based on the type of technology, the dPCR and qPCR market is classified into digital PCR (dPCR) and quantitative PCR (qPCR). In 2017, the qPCR technology segment is expected to account for the largest share of the market. However, the dPCR technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the ongoing technological developments in dPCR, significant adoption of dPCR products among target end users, expansion of distribution networks of emerging dPCR product manufacturers, and growing private funding for the development and commercialization of innovative dPCR instruments.
 
"The dPCR instruments segment is expected to grow at the highest CAGR during 2017-2022."

On the basis of product and service, the dPCR and qPCR market is categorized into instruments; reagents and consumables; and software and services. The dPCR instruments segment is expected to witness the highest growth during the forecast period. The growth of this segment is mainly due to the procedural benefits of dPCR over qPCR, growing market demand for dPCR procedures (particularly in forensics and drug discovery), and rising number of dPCR-based researches across the globe.

"Asia-Pacific to witness the highest growth during the forecast period (2017-2022)"

North America is expected to hold the largest share of the global dPCR and qPCR market in 2017, followed by Europe. However, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period. Growing awareness of physicians & healthcare professionals about the benefits of gene-based disease diagnosis and treatment, growing public-private support to develop novel dPCR and qPCR technologies, strong growth witnessed by the Indian genomics industry, and advancing cancer research in Japan are the key factors responsible for the growth of this market in the Asia-Pacific region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-45%, Tier 2-34% and Tier 3-21%
  • By Designation - Director Level-14%, C-level-10%, Others-76%
  • By Region - North America-40%, Europe-32%, Asia-Pacific-20%, RoW-8%

Some of the major market players in the dPCR and qPCR market are: Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (U.S.), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), and Abbott Laboratories (U.S.), among others.

Research Coverage:
This report studies the dPCR and qPCR market based on technology, product and service, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report forecasts the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The dPCR and qPCR market report profiles key players who are involved in the manufacturing and commercialization of dPCR and qPCR products and analyzes their core competencies. The report tracks and analyzes competitive developments such as new product launches and enhancements; mergers and acquisition; partnerships, collaborations and agreements; and expansions in the dPCR and qPCR market.

Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis-market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the dPCR and qPCR market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the top 10 players in the dPCR and qPCR market. The report analyzes the Digital PCR (dPCR) and qPCR market by technology, product and service, application, end user, and region
  • Product Development/Innovation: Detailed insights on research and development activities, developmental pipeline, and new product launches in the dPCR and qPCR market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various dPCR and qPCR products across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World)
  • Competitive Assessment: Assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the dPCR and qPCR market.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Bioneer Corporation
  • Denville Scientific Inc.
  • Eppendorf AG
  • Formulatrix, Inc.
  • Promega Corporation
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Factor Analysis
           2.2.1 Introduction
           2.2.2 Demand-Side Analysis
                    2.2.2.1 Healthcare Expenditure Patterns
                    2.2.2.2 Rapid Growth of Aging Population
                    2.2.2.3 Incidence and Prevalence of Cancer
                    2.2.2.4 Birth Rate/Pregnancies
                    2.2.2.5 Burden of Infectious Diseases
                    2.2.2.6 Number of Clinical, Forensics, and Research Laboratories
           2.2.3 Supply-Side Analysis
                    2.2.3.1 Number of Product Launches: qPCR and dPCR vs Competitive Technologies
                    2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
    2.3 Market Size Estimation
           2.3.1 Top-Down Approach
           2.3.2 Bottom-Up Approach
                    2.3.2.1 Bottom-Up Approach: dPCR and qPCR Instruments and Software
                    2.3.2.2 Bottom-Up Approach: dPCR and qPCR Reagents
    2.4 Data Triangulation
    2.5 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights
    4.1 dPCR and qPCR Market Overview (2017-2022)
    4.2 Global qPCR and dPCR Technology Market, By Region 2017 Vs.2022 (USD Million)
    4.3 Global qPCR and dPCR Market Share, By Product and Service (2017)
    4.4 Regional Analyiss: qPCR Market, By Application, 2017 vs 2022 (USD Million)
    4.5 Regional Analysis: dPCR Market, By Application, 2017 vs 2022 (USD Million)

5 Market Overview
    5.1 Introduction
    5.2 Technological Evolution in qPCR/dPCR
    5.3 Market Dynamics
           5.3.1 Major Market Drivers
                    5.3.1.1 Rising Incidences of Infectious Diseases and Genetic Disorders
                    5.3.1.2 Technological Advancement in PCR Technologies
                    5.3.1.3 Increasing Public-Private Investments, Funds, and Grants
                    5.3.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics
                    5.3.1.5 Successful Completion of the Human Genome Project
           5.3.2 Major Market Restraints
                    5.3.2.1 High Device Costs Associated With dPCR
                    5.3.2.2 Technical Limitations of qPCR and dPCR Techniques
           5.3.3 Major Market Opportunities
                    5.3.3.1 Growing Market Penetration in Emerging Countries
                    5.3.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
           5.3.4 Major Market Challenges
                    5.3.4.1 Adoption and Implementation of Miqe Guidelines for Publishing qPCR and dPCR-Based Research

6 Industry Trends
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
           6.3.1 Development of Lab-On-Chip PCR Devices
           6.3.2 Ongoing Technological Integration With PCR Process
    6.4 Porter’s Five Forces Analysis
           6.4.1 qPCR Market: Porter’s Five Forces Analysis
           6.4.2 dPCR Market: Porter’s Five Forces Analysis

7 Global qPCR and dPCR Market, By Technology
    7.1 Introduction
    7.2 Quantitative PCR (qPCR)
    7.3 Digital PCR (dPCR)

8 Global qPCR and dPCR Market, By Product and Service
    8.1 Introduction
    8.2 qPCR Products and Services
           8.2.1 qPCR Reagents and Consumables
           8.2.2 qPCR Instruments
           8.2.3 qPCR Software and Services
    8.3 dPCR Products and Services
           8.3.1 dPCR Instruments
           8.3.2 dPCR Reagents and Consumables
           8.3.3 dPCR Software and Services

9 qPCR and dPCR Market, By Application
    9.1 Introduction
    9.2 qPCR Applications
           9.2.1 Clinical Applications
                    9.2.1.1 Pathogen Testing
                    9.2.1.2 Oncology Testing
                    9.2.1.3 Blood Screening
                    9.2.1.4 Other Clinical Applications
           9.2.2 Research Applications
           9.2.3 Forensic Applications
    9.3 dPCR Applications
           9.3.1 Clinical Applications
                    9.3.1.1 Pathogen Testing
                    9.3.1.2 Oncology Testing
                    9.3.1.3 Blood Screening
                    9.3.1.4 Other Clinical Applications
           9.3.2 Research Applications
           9.3.3 Forensic Applications

10 qPCR and dPCR Market, By End User
     10.1 Introduction
     10.2 Quantitative PCR (qPCR) End Users
             10.2.1 Hospitals and Diagnostic Centers
             10.2.2 Research Laboratories and Academic Institutes
             10.2.3 Pharmaceutical and Biotechnology Companies
             10.2.4 Clinical Research Organizations
             10.2.5 Forensic Laboratories
     10.3 Digital PCR (dPCR) End Users
             10.3.1 Research Laboratories and Academic Institutes
             10.3.2 Hospitals and Diagnostic Centers
             10.3.3 Pharmaceutical and Biotechnology Companies
             10.3.4 Clinical Research Organizations
             10.3.5 Forensic Laboratories

11 qPCR and dPCR Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Rest of Europe
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of APAC (RoAPAC)
     11.5 Rest of the World (RoW)

12 Competitive Landscape
     12.1 Overview
     12.2 Vendor Inclusion Criteria
     12.3 Competitive Leadership Mapping
             12.3.1 Visionary Leaders
             12.3.2 Innovators
             12.3.3 Dynamic Differentiators
             12.3.4 Emerging Companies
     12.4 Competitive Benchmarking
             12.4.1 Analysis of Product Portfolio of Major Players in the dPCR and qPCR Market (25 Players)
             12.4.2 Business Strategies Adopted By Major Players in the dPCR and qPCR Market (25 Players)
     12.5 Market Share Analysis
             12.5.1 qPCR Market Share Analysis (2016)
             12.5.2 dPCR Market Share Analysis (2016)

*Top 13 Companies Analysed for This Study are - Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Qiagen N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (U.S.), Biomérieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), ABBott Laboratories (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.), Becton, Dickinson and Company (U.S.), Meridian Bioscience, Inc. (U.S.), Analytik Jena AG (Germany), Eppendorf AG (Germany), Bioneer Corporation (South Korea), Enzo Life Science, Inc. (U.S.), Quanta Biosciences Inc. (U.S.), Elitech Group (France), Formulatrix, Inc. (U.S.), Jn Medsys (Singapore), Denville Scientific Inc. (U.S.), Biomeme Inc. (U.S.), and Biosystemika, Research and Development LLC (Slovenia).

13 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
     13.1 Introduction
     13.2 F. Hoffman-La Roche Ltd.
     13.3 Thermo Fisher Scientific, Inc.
     13.4 Bio-Rad Laboratories, Inc.
     13.5 Qiagen N.V.
     13.6 Takara Bio, Inc.
     13.7 Agilent Technologies, Inc.
     13.8 Biomérieux S.A.
     13.9 Fluidigm Corporation
     13.10 Danaher Corporation
     13.11 ABBott Laboratories
     13.12 Merck KGaA
     13.13 Becton Dickinson and Company
     13.14 Promega Corporation
     13.15 Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
     13.16 Analytik Jena AG (Endress+Hauser Ag)

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

List of Tables
Table 1 Global qPCR and dPCR Market Size, By Technology, 2015-2022 (USD Million)
Table 2 qPCR Technology Market Size, By Region, 2015-2022 (USD Million)
Table 3 dPCR Technology Market Size, By Region, 2015-2022 (USD Million)
Table 4 Global qPCR Products and Services Market Size, By Type, 2015-2022 (USD Million)
Table 5 qPCR Reagents and Consumables Market Size, By Region, 2015-2022 (USD Million)
Table 6 qPCR Instruments Market Size, By Region, 2015-2022 (USD Million)
Table 7 qPCR Software and Services Market Size, By Region, 2015-2022 (USD Million)
Table 8 Global dPCR Products and Services Market Size, By Type, 2015-2022 (USD Million)
Table 9 dPCR Instruments Market Size, By Region, 2015-2022 (USD Million)
Table 10 dPCR Reagents and Consumables Market Size, By Region, 2015-2022 (USD Million)
Table 11 dPCR Software and Services Market Size, By Region, 2015-2022 (USD Million)
Table 12 Global qPCR Market Size, By Application, 2015-2022 (USD Million)
Table 13 qPCR Clinical Applications Market Size, By Type, 2015-2022 (USD Million)
Table 14 qPCR Clinical Applications Market Size, By Region, 2015-2022 (USD Million)
Table 15 qPCR Clinical Application Market Size for Pathogen Testing, By Region, 2015-2022 (USD Million)
Table 16 qPCR Clinical Application Market Size for Oncology Testing, By Region, 2015-2022 (USD Million)
Table 17 qPCR Clinical Application Market Size for Blood Screening, By Region, 2015-2022 (USD Million)
Table 18 qPCR Other Clinical Applications Market Size, By Region, 2015-2022 (USD Million)
Table 19 qPCR Research Applications Market Size, By Region, 2015-2022 (USD Million)
Table 20 qPCR Forensic Applications Market Size, By Region, 2015-2022 (USD Million)
Table 21 Global dPCR Market Size, By Application, 2015-2022 (USD Million)
Table 22 dPCR Clinical Applications Market Size, By Type, 2015-2022 (USD Million)
Table 23 dPCR Clinical Applications Market Size, By Region, 2015-2022 (USD Million)
Table 24 dPCR Clinical Application Market Size for Pathogen Testing, By Region, 2015-2022 (USD Million)
Table 25 dPCR Clinical Application Market Size for Oncology Testing, By Region, 2015-2022 (USD Million)
Table 26 dPCR Clinical Application Market Size for Blood Screening, By Region, 2015-2022 (USD Million)
Table 27 dPCR Other Clinical Applications Market Size, By Region, 2015-2022 (USD Million)
Table 28 dPCR Research Applications Market Size, By Region, 2015-2022 (USD Million)
Table 29 dPCR Forensic Applications Market Size, By Region, 2015-2022 (USD Million)
Table 30 Global qPCR Market Size, By End User, 2015-2022 (USD Million)
Table 31 qPCR Market Size for Hospitals and Diagnostic Centers, By Region, 2015-2022 (USD Million)
Table 32 qPCR Market Size for Research Laboratories and Academic Institutes, By Region, 2015-2022 (USD Million)
Table 33 qPCR Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 34 qPCR Market Size for Clinical Research Organizations, By Region, 2015-2022 (USD Million)
Table 35 qPCR Market Size for Forensic Laboratories, By Region, 2015-2022 (USD Million)
Table 36 Global dPCR Market Size, By End User, 2015-2022 (USD Million)
Table 37 dPCR Market Size for Research Laboratories and Academic Institutes, By Region, 2015-2022 (USD Million)
Table 38 dPCR Market Size for Hospitals and Diagnostic Centers, By Region, 2015-2022 (USD Million)
Table 39 dPCR Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 40 dPCR Market Size for Clinical Research Organizations, By Region, 2015-2022 (USD Million)
Table 41 dPCR Market Size for Forensic Laboratories, By Region, 2015-2022 (USD Million)
Table 42 qPCR and dPCR Market Size, By Region, 2015-2022 (USD Million)
Table 43 North America: dPCR and qPCR Market Size, By Country, 2015-2022 (USD Million)
Table 44 North America: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 45 North America: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 46 North America: qPCR Market Size, By Application, 2015-2022 (USD Million)
Table 47 North America: dPCR Market Size, By Application, 2015-2022 (USD Million)
Table 48 North America: qPCR Market Size, By End User, 2015-2022 (USD Million)
Table 49 North America: dPCR Market Size, By End User, 2015-2022 (USD Million)
Table 50 U.S.: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 51 U.S.: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 52 Canada: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 53 Canada: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 54 Europe: dPCR and qPCR Market Size, By Country, 2015-2022 (USD Million)
Table 55 Europe: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 56 Europe: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 57 Europe: qPCR Market Size, By Application, 2015-2022 (USD Million)
Table 58 Europe: dPCR Market Size, By Application, 2015-2022 (USD Million)
Table 59 Europe: qPCR Market Size, By End User, 2015-2022 (USD Million)
Table 60 Europe: dPCR Market Size, By End User, 2015-2022 (USD Million)
Table 61 Germany: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 62 Germany: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 63 U.K.: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 64 U.K.: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 65 France: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 66 France: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 67 RoE: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 68 RoE: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 69 APAC: dPCR and qPCR Market Size, By Country, 2015-2022 (USD Million)
Table 70 Asia-Pacific: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 71 Asia-Pacific: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 72 Asia-Pacific: qPCR Market Size, By Application, 2015-2022 (USD Million)
Table 73 Asia-Pacific: dPCR Market Size, By Application, 2015-2022 (USD Million)
Table 74 Asia-Pacific: qPCR Market Size, By End User, 2015-2022 (USD Million)
Table 75 Asia-Pacific: dPCR Market Size, By End User, 2015-2022 (USD Million)
Table 76 Japan: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 77 Japan: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 78 China: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 79 China: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 80 India: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 81 India: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 82 RoAPAC: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 83 RoAPAC: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 84 RoW: qPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 85 RoW: dPCR Market Size, By Product & Service, 2015-2022 (USD Million)
Table 86 RoW: qPCR Market Size, By Application, 2015-2022 (USD Million)
Table 87 RoW: dPCR Market Size, By Application, 2015-2022 (USD Million)
Table 88 RoW: qPCR Market Size, By End User, 2015-2022 (USD Million)
Table 89 RoW: dPCR Market Size, By End User, 2015-2022 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Healthcare Expenditure Across Major Countries: 2000-2014
Figure 3 Healthcare Expenditure Across Major Regions: 2000-2014
Figure 4 Increase in Aging Population, By Country (2011-2030)
Figure 5 Percentage Increase in Aging Population, By Region (1980-2010 vs 2010-2040)
Figure 6 Global Burden of Cancer, By Region (2005-2030)
Figure 7 Number of New Cancer Cases, By Country (2012 vs 2020)
Figure 8 Increasing Incidence of Various Cancers, 2008-2020
Figure 9 Annual Birth Rate Across Developed and Developing Nations (2016)
Figure 10 Global Prevalence of HIV Infections Among Adults (2015)
Figure 11 Number of Product Launches: qPCR and dPCR vs Competitive Modalities, 2013-2016
Figure 12 dPCR is Expected to Be the Fastest-Growing PCR Techology Till 2022
Figure 13 Top-Down Approach
Figure 14 Data Triangulation
Figure 15 Assumptions of the Research Study
Figure 16 Global dPCR and qPCR Market, By Technology, 2017 vs 2022
Figure 17 Global qPCR Product and Services Market, 2017 vs 2022
Figure 18 Global dPCR Product and Services Market, 2017 vs 2022
Figure 19 Global qPCR Applications Market, 2017 vs 2022
Figure 20 Global dPCR Applications Market, 2017 vs 2022
Figure 21 dPCR and qPCR Market Share, By Region, 2017
Figure 22 Market Growth Opportunities in the dPCR and qPCR Industry
Figure 23 North America Expected to Dominate qPCR and dPCR Markets
Figure 24 Reagents and Consumables to Dominate the qPCR and dPCR Products and Services Markets in 2017
Figure 25 Clinical Application to Command the Largest Share of qPCR Market Across All Regions in 2017
Figure 26 Clinical Application to Command the Largest Share of dPCR Market Across All Regions in 2017
Figure 27 Key Evolutionary Milestones in the Field of qPCR and dPCR
Figure 28 Increasing Prevalence of Infectious Diseases and Genetic Disorders to Drive the Market Demand for dPCR and qPCR Products
Figure 29 Global Burden of Hiv Infections, By Region, 2015
Figure 30 Growing Geriatric Population Across Key Geographies (2015 vs 2030)
Figure 31 Traditional PCR vs qPCR and dPCR: A Comparative Study
Figure 32 Percentage Change in Annual Healthcare Expenditure-Developed vs Developing Countries (2010-2014)
Figure 33 Value Chain Analysis (2012-2017): Majority of Value is Added to Overall Product Price During Manufacturing Phase
Figure 34 Bundled Sales Strategy Adopted By Key Product Manufacturers is Limiting Threat From New Entrants
Figure 35 Growing Number of New Entrants is Augmenting the Growing Market Competition
Figure 36 dPCR Technology Segment is Projected to Grow Faster Than qPCR Technology Segment During the Forecast Period
Figure 37 Reagents & Consumables Segment is Expected to Dominate the qPCR Products & Services Market During 2017-2022
Figure 38 Instruments are Expected to Dominate the dPCR Products & Services Market During 2017-2022
Figure 39 Clinical Application to Dominate the Global qPCR Market During 2017-2022
Figure 40 Clinical Applications to Dominate the Global dPCR Market During 2017-2022
Figure 41 Hospitals and Diagnostic Centers to Dominate the qPCR End User Market During 2017-2022
Figure 42 Research Labs and Academic Institutes to Dominate the dPCR End-User Market During 2017-2022
Figure 43 North America: dPCR and qPCR Market Snapshot
Figure 44 Europe: dPCR and qPCR Market Snapshot
Figure 45 Asia-Pacific: dPCR and qPCR Market Snapshot
Figure 46 RoW: dPCR and qPCR Market Snapshot
Figure 47 dPCR and qPCR Market: Global Competitive Leadership Mapping
Figure 48 Global qPCR Market Share Analysis, By Key Player (2016)
Figure 49 Global dPCR Market Share Analysis, By Key Player (2016)
Figure 50 Geographic Revenue Mix of the Top 5 Market Players (2016)
Figure 51 F. Hoffmann-La Roche Ltd.: Company Snapshot (2016)
Figure 52 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 53 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 54 Qiagen N.V.: Company Snapshot (2016)
Figure 55 Takara Bio, Inc.: Company Snapshot (2016)
Figure 56 Agilent Technologies, Inc.: Company Snapshot (2016)
Figure 57 Biomérieux S.A.: Company Snapshot (2016)
Figure 58 Fluidigm Corporation: Company Snapshot (2016)
Figure 59 Danaher Corporation: Company Snapshot (2016)
Figure 60 ABBott Laboratories: Company Snapshot (2016)
Figure 61 Merck KGaA: Company Snapshot
Figure 62 Becton Dickinson and Company: Company Snapshot (2016)
Figure 63 Meridian Bioscience, Inc.: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Bioneer Corporation
  • Denville Scientific Inc.
  • Eppendorf AG
  • Formulatrix, Inc.
  • Promega Corporation
  • MORE

The global dPCR and qPCR market is expected to reach USD 5.31 Billion by 2022, growing at a CAGR of 8.9% during 2017-2022. Factors such as the growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, technological advancements in the field of PCR, and increasing investments and availability of funds for PCR-based research are driving the growth of the global dPCR and qPCR market. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market. In addition to this, adoption and implementation of MIQE guidelines for publishing qPCR and dPCR-based research pose a key challenge for players operating in this market.

On the basis of technology, the global dPCR and qPCR market is divided into two categories, namely, quantitative/real-time PCR (qPCR) and digital PCR (dPCR). On the basis of product and service, the market is categorized into instruments; reagents and consumables; and software and services. On the basis of application, the dPCR and qPCR market is divided into clinical applications, research applications, and forensic applications. The dPCR and qPCR clinical application is further sub-segmented into pathogen testing, oncology testing, blood screening, and other clinical applications. On the basis of end user, the dPCR and qPCR market is categorized into research laboratories and academic institutes, pharma and biotech companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories. The dPCR technology segment is expected to grow at the highest CAGR during the forecast period, owing to the ongoing technological developments in dPCR, significant adoption rate of dPCR products among target end-users, continued expansion in distribution networks of emerging dPCR product manufacturers, and growing private funding for the development and commercialization of innovative dPCR instruments.

Geographically, this market is classified into North America (U.S. and Canada), Europe (Germany, U.K., France, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and the Rest of the World. In 2017, the global dPCR and qPCR market is expected to be dominated by North America, followed by Europe. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, owing to the growing awareness of physicians & healthcare professionals about the benefits of gene-based disease diagnosis and treatment, growing public-private support to develop novel dPCR and qPCR technologies, and strong growth witnessed by the Indian genomics industry.

Digital PCR and Real-time PCR (qPCR) Market

New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global dPCR and qPCR market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global dPCR and qPCR market.

As of 2016, Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (U.S.), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), and Abbott Laboratories (U.S.) were some of the key players operating in the global dPCR and qPCR market.

Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena AG (Endress+Hauser Ag)
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomeme Inc.
  • Biomérieux S.A.
  • Bioneer Corporation
  • Biosystemika
  • Danaher Corporation
  • Denville Scientific Inc.
  • Elitech Group
  • Enzo Life Science, Inc.
  • Eppendorf AG
  • F. Hoffman-La Roche Ltd.
  • Fluidigm Corporation
  • Formulatrix, Inc.
  • Jn Medsys
  • Merck KGaA
  • Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
  • Promega Corporation
  • Qiagen N.V.
  • Quanta Biosciences Inc.
  • Research and Development LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll